Etomidate impurity B

Get a Price/Quote

MOQ : 1 Kilograms

Etomidate impurity B Specification

Usage
Intravenous Etomidate injection is also indicated for the supplementation of subpotent anesthetic agents, such as nitrous oxide in oxygen, during maintenance of anesthesia for short operative procedures such as dilation and curettage or cervical conization.

Molecular Weight
244.29 Grams (g)

Molecular Formula
C14H16N2O2

Purity
98%

Melting Point
67 °C (153 °F)

Etomidate impurity B Trade Information

Minimum Order Quantity
1 Kilograms

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
500 Kilograms kg Per Month

Delivery Time
2-8 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Carton and Poly Bag.

Main Export Market(s)
South America, Australia, Eastern Europe, Middle East, Central America, Africa, Western Europe, Asia, North America

Main Domestic Market
All India

About Etomidate impurity B

Etomidate impurity BEuropean Pharmacopoeia (EP) Reference StandardSynonym: Methyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylateCAS Number5377-20-8Empirical Formula (Hill Notation)C13H14N2O2Molecular Weight230.26PropertiesRelated CategoriesAnalytical Standards,Analytical/Chromatography,EP Standards,EP Standards E - F,Pharmacopeia & Metrological Institutes StandardsLess...form neatformat neat

FAQs of Etomidate impurity B:

Q: What is the purity level of Etomidate impurity B?

A: The purity level of Etomidate impurity B is 98%.

Q: What is the molecular formula of Etomidate impurity B?

A: The molecular formula of Etomidate impurity B is C14H16N2O2.

Q: What is the melting point of Etomidate impurity B?

A: The melting point of Etomidate impurity B is 67 C (153 F).

Q: What is the molecular weight of Etomidate impurity B?

A: The molecular weight of Etomidate impurity B is 244.29 Grams (g).

Q: What is the usage of Etomidate impurity B?

A: Etomidate impurity B is used in intravenous Etomidate injection, indicated for the supplementation of subpotent anesthetic agents, such as nitrous oxide in oxygen, during maintenance of anesthesia for short operative procedures such as dilation and curettage or cervical conization.

Tell us about your requirement